-
EP2133347
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2133347
| EP2133347 - 1-BIARYLAZETIDINONE DERIVATIVES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.10.2013 Database last updated on 18.11.2024 | Most recent event Tooltip | 25.10.2013 | Application deemed to be withdrawn | published on 27.11.2013 [2013/48] | Applicant(s) | For all designated states Teijin Pharma Limited 2-1, Kasumigaseki 3-chome Chiyoda-ku Tokyo 100-0013 / JP | [2009/51] | Inventor(s) | 01 /
NAKANO, Akira c/o Teijin Pharma Limited Tokyo Research Center 3-2 Asahigaoka 4-chome Hino-shi Tokyo 191-0065 / JP | 02 /
NAKAJIMA, Ryota c/o Teijin Pharma Limited Tokyo Research Center 3-2 Asahigaoka 4-chome Hino-shi Tokyo 191-0065 / JP | 03 /
KANOU, Masanobu c/o Teijin Pharma Limited Tokyo Research Center 3-2 Asahigaoka 4-chome Hino-shi Tokyo 191-0065 / JP | 04 /
HISAMATSU, Seiichi c/o Teijin Pharma Limited Tokyo Research Center 3-2 Asahigaoka 4-chome Hino-shi Tokyo 191-0065 / JP | 05 /
KUROKAWA, Masayuki c/o Teijin Pharma Limited Tokyo Research Center 3-2 Asahigaoka 4-chome Hino-shi Tokyo 191-0065 / JP | 06 /
NISHIWAKI, Yasumi c/o Teijin Pharma Limited Tokyo Research Center 3-2 Asahigaoka 4-chome Hino-shi Tokyo 191-0065 / JP | [2009/51] | Representative(s) | Hallybone, Huw George, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2009/51] | Hallybone, Huw George, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 08721668.5 | 04.03.2008 | [2009/51] | WO2008JP54252 | Priority number, date | JP20070055923 | 06.03.2007 Original published format: JP 2007055923 | JP20070202109 | 02.08.2007 Original published format: JP 2007202109 | [2009/51] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008108486 | Date: | 12.09.2008 | Language: | JA | [2008/37] | Type: | A1 Application with search report | No.: | EP2133347 | Date: | 16.12.2009 | Language: | EN | [2009/51] | Search report(s) | International search report - published on: | JP | 12.09.2008 | (Supplementary) European search report - dispatched on: | EP | 17.02.2010 | Classification | IPC: | C07D401/10, A61K31/397, A61K31/404, A61K31/4427, A61K31/497, A61K31/506, A61K31/706, A61P3/06, A61P9/10, C07D401/14, C07D403/10, C07D405/14, C07D409/14, C07H15/26 | [2009/51] | CPC: |
C07D401/10 (EP,US);
A61P3/00 (EP);
A61P3/06 (EP);
A61P9/10 (EP);
C07D401/14 (EP,US);
C07D403/10 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/51] | Title | German: | 1-BIARYLAZETIDINONDERIVATE | [2009/51] | English: | 1-BIARYLAZETIDINONE DERIVATIVES | [2009/51] | French: | DÉRIVÉS DE 1-BIARYLAZÉTIDINONE | [2009/51] | Entry into regional phase | 06.10.2009 | Translation filed | 06.10.2009 | National basic fee paid | 06.10.2009 | Search fee paid | 06.10.2009 | Designation fee(s) paid | 06.10.2009 | Examination fee paid | Examination procedure | 06.10.2009 | Amendment by applicant (claims and/or description) | 06.10.2009 | Examination requested [2009/51] | 22.01.2013 | Communication of intention to grant the patent | 04.06.2013 | Application deemed to be withdrawn, date of legal effect [2013/48] | 09.07.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2013/48] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.01.2013 | Fees paid | Renewal fee | 15.03.2010 | Renewal fee patent year 03 | 15.03.2011 | Renewal fee patent year 04 | 14.03.2012 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.03.2013 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO2008039829 (MICROBIA INC [US], et al) [E] 1-15 * the whole document *; | [A] - AGARWAL R ET AL, "SYNTHESIS OF 1-SUBSTITUTED-2-OXO-3-CHLORO/3-(2-CHLOROPHENOXY)-4- (2-ARYLINDOL-3-YL)AZETIDINES AS CNS ACTIVE AND ANTIINFLAMMATORY AGENTS", INDIAN JOURNAL OF CHEMISTRY, JODHPUR, IN, (19891001), vol. 28B, no. 10, pages 893 - 896, XP002910249 [A] 1-15 * the whole document * | International search | [A]JPH06508637 (SCHERING CORP) [A] 1-23 * , & EP 524595 A1 & WO 93/02048 A1 *; | [A]JP2006501184 (ASTRAZENECA AB) [A] 1-23 * , & WO 2004/005247 A1 & EP 1521742 A1 & US 2005/239766 A1 *; | [A]WO2006124713 (MICROBIA INC [US], et al) [A] 1-23 * , (Family: none) *; | [A]WO2006137795 (ASTRAZENECA AB [SE], et al) [A] 1-23* , (Family: none) *; | [A]JP2007520453 (MICROBIA INC, US) [A] 1-23 * , & WO 2005/047248 A1 & US 2005/209165 A1 & EP 1682499 A1 * | by applicant | WO9302048 | WO9508532 | WO9526334 | WO9535277 | WO9616037 | WO2005033100 | WO2005047248 | WO2005113495 | WO2006121861 | WO2006124713 | - ANDRE J., TREMBLAY, ARTERIOSCLER. THROMB. VASC. BIOL., (2006), vol. 26, pages 1101 - 1106 | - V.CHARLTON-MENYS, EXP. PHYSIOL., (2007), vol. 93, no. 1, pages 27 - 42 | - H ISO, AM. J. EPIDEMIOL., (2001), vol. 153, pages 490 - 499 | - T GORDON, ARCH INTERN. MED., (1981), vol. 141, pages 1128 - 1131 | - RELE, S.M. ET AL., J. ORG. CHEM., (2004), vol. 69, pages 9159 - 9170 |